COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,582 Articles (22,415 medRxiv, 8,167 bioRxiv)

Most recent first Previous |  Page 1003: Articles 10021-10030  | Next

Oral antiviral clevudine compared with placebo in Korean COVID-19 patients with moderate severity
Song, J.-Y., Kim, Y.-S., Eom, J.-S., Kim, J.-Y., Lee, J.-S., Lee, J., Choi, W.-S., Heo, J.-Y., Sohn, J.-W., Lee, K.-D., Cho, D., Cho, I., Kim, W.-J.
10.1101/2021.12.09.21267566 — Posted: 2021-12-14
Microarray-based detection of antibodies against SARS-CoV-2 proteins, common respiratory viruses and type I interferons
Savvateeva, E., Filippova, M., Valuev-Elliston, V., Nuralieva, N., Yukina, M., Troshina, E., Baklaushev, V., Ivanov, A., Gryadunov, D.
10.1101/2021.12.13.21267509 — Posted: 2021-12-14
Age-specific Contribution of Contacts to Transmission of SARS-CoV-2 in Germany
Rodiah, I., Vanella, P., Kuhlmann, A., Jaeger, V., Harries, M., Krause, G., Bock, W., Lange, B.
10.1101/2021.12.13.21267716 — Posted: 2021-12-14
Production and secretion of functional full-length SARS-CoV-2 spike protein in Chlamydomonas reinhardtii
Kiefer, A., Niemeyer, J., Probst, A., Erkel, G., Schroda, M.
10.1101/2021.12.13.472433 — Posted: 2021-12-14
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern
Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O'Connell, A.-M., Simons, D., Blomquist, P. B., Dabrera, G., Myers, R., Ladhani, S. N., Amirthalingam, G., Gharbia, S., Barrett, J. C., Elson, R., Ferguson, N., Zambon, M., Campbell, C. N., Brown, K., Hopkins, S., Chand, M., Ramsay, M., Lopez Bernal, J.
10.1101/2021.12.14.21267615 — Posted: 2021-12-14
Isolation and Characterization of SARS-CoV-2 strains circulating in Eastern India.
Singh, B., Avula, K., Chatterjee, S., Datey, A., Ghosh, A., De, S., Keshry, S. S., Ghosh, S., Suryawanshi, A. R., Dash, R., Senapati, S., Beuria, T. K., Prasad, P., Raghav, S., Swain, R. K., Parida, A., Syed, G. H., Chattopadhyay, S.
10.1101/2021.12.13.472526 — Posted: 2021-12-14
High temporal resolution transcriptomic profiling delineates distinct patterns of interferon response following Covid-19 mRNA vaccination and SARS-CoV2 infection
Rinchai, D., Deola, S., Zoppoli, G., Kabeer, B. S. A., Taleb, S. A., Pavlovski, I., Maacha, S., Gentilcore, G., Toufiq, M., Matthew, L., Liu, L., Vempalli, F. R., Mubarak, G., Lorenz, S., Sivieri, I., Cirmena, G., Dentone, C., Cuccarolo, P., Giacobbe, D., Baldi, F., Garbarino, A., Cigolini, B., Cremonesi, P., Bedognetti, M., Ballestrero, A., Bassetti, M., Hejblum, B. P., Augustine, T., Panhuys, N. V., Thiebaut, R., Branco, R., Chew, T., Shojaei, M., Short, K., Feng, C., Zughaier, S. M., Maria, A. D., Tang, B., Hssain, A. A., Bedognetti, D., Grivel, J.-C., Chaussabel, D.
10.1101/2021.12.12.472257 — Posted: 2021-12-14
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Cameroni, E., Saliba, C., Bowen, J. E., Rosen, L. E., Culap, K., Pinto, D., De Marco, A., Zepeda, S. K., di Iulio, J., Zatta, F., Kaiser, H., Noack, J., Farhat, N., Czudnochowski, N., Havenar-Daughton, C., Sprouse, K. R., Dillen, J. R., Powell, A. E., Chen, A., Maher, C., Yin, L., Sun, D., Soriaga, L., Gustafsson, C., Chu, H., Franko, N. M., Logue, J., Iqbal, N. T., Mazzitelli, I., Geffner, J., Grifantini, R., Gori, A., Riva, A., Giannini, O., Ceschi, A., Ferrari, P., Franzetti-Pellanda, A., Garzoni, C., Hebner, C., Purcell, L., Piccoli, L., Pizzuto, M. S., Walls, A. C., Telenti, A., Virgin, H. W., Lanzavecchia, A., Veesler, D., Snell, G., Corti, D.
10.1101/2021.12.12.472269 — Posted: 2021-12-14
Assessing impact of Omicron on SARS-CoV-2 dynamics and public health burden
Le Rutte, E. A., Shattock, A. J., Chitnis, N., Kelly, S. L., Penny, M. A.
10.1101/2021.12.12.21267673 — Posted: 2021-12-14
Scanning the RBD-ACE2 molecular interactions in Omicron variant
Rath, S. L., Padhi, A. K., Mandal, N.
10.1101/2021.12.12.472253 — Posted: 2021-12-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).